Brain Neoplasm clinical trials
Showing 51–74 of 74 active trials. Describe your situation to see which ones you may be eligible for.
- Model-based Electrical Brain Stimulation
- Ommaya Reservoir Placement for Brain Tumor Biomarker Access
- Pain Control and Quality of Recovery After Intravenous Methadone Versus Intravenous Remifentanil in Craniotomy Surgery
- Systematic Light Exposure in Pediatric Brain Tumor Survivors
- Feasibility of Transcranial Focused Ultrasound to Measure Brain Tumor
- High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study
- MCT for the Harvard/UCSF ROBIN Center
- Mapping of Human Cognition
- Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
- Asciminib With or Without Sildenafil for Brain Tumors
- Lipid Mediators & Cancer: Montelukast, SPM, and Almonds
- Listen Aphasia Pilot Study
- Real Time Craniotomy Planning Using Mixed Reality
- Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer
- Use of Shear Wave Elastography for Intraoperative Brain and Tumor Stiffness Measurements
- Functional Organization of the Superior Temporal Gyrus for Speech Perception
- The Neural Coding of Speech Across Human Languages
- Comparison of Post-Craniotomy Blood Pressure Targets
- Neuronal and Network Mechanisms of Electrocortical Stimulation
- Home Transcranial Direct Current Stimulation (tDCS) to Enhance Functional Recovery
- Quality Improvement and Practice Based Research in Neurology Using the EMR
- A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
- Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker
- Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.